Search results
Hindenburg Gave Adani Report To Client 2 Months Before Publishing: SEBI
NDTV· 22 hours agoThe capital markets regulator Securities and Exchange Board of India (SEBI), in its 46-page show...
Hindenburg showed Adani’s report to client two months before publishing: SEBI | Mint
Livemint· 23 hours agoSEBI issued a show cause notice to Hindenburg Research, stating how the short seller, the New...
Hindenburg shared Adani report with client two months before publishing it: Sebi
Hindustan Times· 24 hours agoSebi charged Hindenburg of making "unfair" profits from "collusion" to...
Moneycontrol Selects: Top stories this evening
CNBC Awaaz· 1 day agoFinance Minister Nirmala Sitharaman has wrapped up consultations with various stakeholders, including representatives of industry and social sectors,...
Jagannath Rath Yatra 2024: Yatra begins today, PM Modi greets people - Yatra begins today
The Economic Times· 1 day agoOn Sunday, July 7, 2024, Odisha's Puri started the inaugural two-day Jagannath Rath Yatra.This is a...
New details emerge in Adani-Hindenburg saga: Early deal with Mark Kingdon, market maneuvers and...
The Economic Times· 1 day agoAfter Kotak and the Chinese spy twist, more details have emerged in the Adani-Hindenburg saga. As...
Hindenburg Research shared Adani Group report with client two months before publishing it: Sebi
The Telegraph· 1 day agoThe Securities and Exchange Board of India (Sebi), in its 46-page show cause notice to Hindenburg,...
After Kotak twist & China spies, Hindenburg vs Adani gets murkier as new details emerge in the drama
The Economic Times· 1 day agoAfter Kotak and the Chinese spy twist, more details have emerged in the Adani-Hindenburg saga. As...
Hindenburg shared Adani report with client two months before publishing it: Sebi
CNBC Awaaz· 1 day agoThe Securities and Exchange Board of India (Sebi), in its 46-page show cause notice to Hindenburg,...
Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status. -...
The Economic Times· 1 day agoEmcure Pharmaceuticals received a robust response from investors for its IPO, which closed last...